Zinc and diabetes--clinical links and molecular mechanisms
- PMID: 19442898
- DOI: 10.1016/j.jnutbio.2009.01.009
Zinc and diabetes--clinical links and molecular mechanisms
Abstract
Zinc is an essential trace element crucial for the function of more than 300 enzymes and it is important for cellular processes like cell division and apoptosis. Hence, the concentration of zinc in the human body is tightly regulated and disturbances of zinc homeostasis have been associated with several diseases including diabetes mellitus, a disease characterized by high blood glucose concentrations as a consequence of decreased secretion or action of insulin. Zinc supplementation of animals and humans has been shown to ameliorate glycemic control in type 1 and 2 diabetes, the two major forms of diabetes mellitus, but the underlying molecular mechanisms have only slowly been elucidated. Zinc seems to exert insulin-like effects by supporting the signal transduction of insulin and by reducing the production of cytokines, which lead to beta-cell death during the inflammatory process in the pancreas in the course of the disease. Furthermore, zinc might play a role in the development of diabetes, since genetic polymorphisms in the gene of zinc transporter 8 and in metallothionein (MT)-encoding genes could be demonstrated to be associated with type 2 diabetes mellitus. The fact that antibodies against this zinc transporter have been detected in type 1 diabetic patients offers new diagnostic possibilities. This article reviews the influence of zinc on the diabetic state including the molecular mechanisms, the role of the zinc transporter 8 and MT for diabetes development and the resulting diagnostic and therapeutic options.
Similar articles
-
Role of zinc and zinc transporters in the molecular pathogenesis of diabetes mellitus.Med Hypotheses. 2005;65(5):887-92. doi: 10.1016/j.mehy.2005.02.047. Med Hypotheses. 2005. PMID: 16043303
-
Zinc, the pancreas, and diabetes: insights from rodent studies and future directions.Biometals. 2005 Aug;18(4):305-12. doi: 10.1007/s10534-005-3686-x. Biometals. 2005. PMID: 16158221 Review.
-
Zinc signalling and subcellular distribution: emerging targets in type 2 diabetes.Trends Mol Med. 2008 Oct;14(10):419-28. doi: 10.1016/j.molmed.2008.08.002. Epub 2008 Sep 4. Trends Mol Med. 2008. PMID: 18774338
-
Beta-cell function and mass in type 2 diabetes.Dan Med Bull. 2009 Aug;56(3):153-64. Dan Med Bull. 2009. PMID: 19728971
-
Fate of the beta-cell in the pathophysiology of type 2 diabetes.J Am Pharm Assoc (2003). 2009 Sep-Oct;49 Suppl 1:S10-5. doi: 10.1331/JAPhA.2009.09076. J Am Pharm Assoc (2003). 2009. PMID: 19801360 Review.
Cited by
-
Current Research on Zinc Oxide Nanoparticles: Synthesis, Characterization, and Biomedical Applications.Nanomaterials (Basel). 2022 Sep 3;12(17):3066. doi: 10.3390/nano12173066. Nanomaterials (Basel). 2022. PMID: 36080103 Free PMC article. Review.
-
Serum levels of copper and zinc in diabetic retinopathy: Potential new therapeutic targets (Review).Exp Ther Med. 2022 May;23(5):324. doi: 10.3892/etm.2022.11253. Epub 2022 Mar 11. Exp Ther Med. 2022. PMID: 35386624 Free PMC article. Review.
-
Emerging Theranostic Nanomaterials in Diabetes and Its Complications.Adv Sci (Weinh). 2022 Jan;9(3):e2102466. doi: 10.1002/advs.202102466. Epub 2021 Nov 25. Adv Sci (Weinh). 2022. PMID: 34825525 Free PMC article. Review.
-
The immune system and the impact of zinc during aging.Immun Ageing. 2009 Jun 12;6:9. doi: 10.1186/1742-4933-6-9. Immun Ageing. 2009. PMID: 19523191 Free PMC article.
-
A calcium channel blocker nifedipine distorts the effects of nano-zinc oxide on metal metabolism in the marsh frog Pelophylax ridibundus.Saudi J Biol Sci. 2019 Mar;26(3):481-489. doi: 10.1016/j.sjbs.2017.10.004. Epub 2017 Oct 4. Saudi J Biol Sci. 2019. PMID: 30899162 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical